AG
GBT

Advisor Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Advisor Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$91K Buy
1,145
+307
+37% +$18.2K ﹤0.01% 3012
2019
Q3 		$40K Sell
838
-10,566
-93% -$551K ﹤0.01% 3546
2019
Q2 		$600K Buy
11,404
+10,594
+1,308% +$609K ﹤0.01% 1489
2019
Q1 		$43K Buy
810
+110
+16% +$5.41K ﹤0.01% 3499
2018
Q4 		$28K Sell
700
-247
-26% -$9.26K ﹤0.01% 3599
2018
Q3 		$36K Sell
947
-553
-37% -$24.5K ﹤0.01% 3524
2018
Q2 		$68K Sell
1,500
-655
-30% -$29.8K ﹤0.01% 2846
2018
Q1 		$104K Buy
2,155
+555
+35% +$31K ﹤0.01% 2533
2017
Q4 		$63K Sell
1,600
-150
-9% -$5.6K ﹤0.01% 2924
2017
Q3 		$54K Buy
+1,750
New +$49.2K ﹤0.01% 2889
2017
Q2 		– Sell
-25
Closed -$1K – 4956
2017
Q1 		$1K Buy
+25
New +$630 ﹤0.01% 4613

Other funds holding GBT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Advisor Group's GBT Position: Q4 2019 in Review

Advisor Group increased its Global Blood Therapeutics, Inc. (GBT) stake by 37% in Q4 2019, buying an estimated $18.2K and bringing the position to 1,145 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Advisor Group first reported a position in GBT in Q1 2017 and has held it in 11 quarters since. The position peaked at $600K in Q2 2019. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

  • Advisor Group held 1,145 shares of Global Blood Therapeutics, Inc. worth $91K as of Q4 2019.
  • Advisor Group bought 307 Global Blood Therapeutics, Inc. shares in Q4 2019, an estimated $18.2K.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3012 holding.
  • Advisor Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and has held it in 11 quarters since.
  • Advisor Group's Global Blood Therapeutics, Inc. position peaked at $600K in Q2 2019.
  • 234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.